北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学精神卫生研究所  > 期刊论文
学科主题: 精神卫生
题名:
Once-daily duloxetine 60 mg in the treatment of major depressive disorder: Multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil
作者: Lee, Phil; Shu, Liang; Xu, Xiufeng; Wang, Chuan Yue; Lee, Min Soo; Liu, Chia-Yih; Hong, Jin Pyo; Ruschel, Sandra; Raskin, Joel; Colman, Samuel A.; Harrison, Gavan A.
关键词: Asia ; duloxetine ; major depressive disorder ; MDD ; paroxetine
刊名: PSYCHIATRY AND CLINICAL NEUROSCIENCES
发表日期: 2007-06-01
DOI: 10.1111/j.1440-1819.2007.01666.x
卷: 61, 期:3, 页:295-307
收录类别: SCI ; SSCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Clinical Neurology ; Neurosciences ; Psychiatry
研究领域[WOS]: Neurosciences & Neurology ; Psychiatry
关键词[WOS]: SEROTONIN REUPTAKE INHIBITORS ; PAINFUL PHYSICAL SYMPTOMS ; PLACEBO-CONTROLLED TRIAL ; PRIMARY-CARE ; REMISSION RATES ; EFFICACY ; SAFETY ; ANTIDEPRESSANTS ; TOLERABILITY ; VENLAFAXINE
英文摘要:

The aim of the present paper was to compare the efficacy and safety of duloxetine with paroxetine in the acute treatment of major depressive disorder (MDD). In a randomized, double-blind trial of 8 weeks active treatment, patients with non-psychotic MDD were randomized to duloxetine 60 mg (n = 238) or paroxetine 20 mg (n = 240) once daily. Efficacy was primarily measured on change in the 17-item Hamilton Rating Scale for Depression (HAMD(17)) using a non-inferiority test with a margin of 2.2. Secondary efficacy measures included the HAMD(17) subscales, Hamilton Rating Scale for Anxiety, Clinical Global Impressions-Severity, Patient Global Impressions-Improvement, Somatic Symptoms Inventory and Visual Analog Scales (VAS) for pain. Safety measures included treatment-emergent adverse events (TEAE), vital signs, weight, laboratory analyses and electrocardiograms. Non-inferiority of duloxetine to paroxetine was demonstrated because the upper bound of the confidence interval for mean difference in HAMD(17) change (0.71) was less than the non-inferiority margin. Secondary efficacy end-points did not differ significantly between treatments with the exception of VAS back pain, where the pooled mean was lower in the duloxetine group (17.1) compared with the paroxetine group (20.3, P = 0.048). No significant differences were observed in the number of early discontinuations and overall TEAE. However, significantly greater proportions of patients in the duloxetine group experienced nausea and palpitations. No clinically relevant changes in laboratory values, vital signs, weight or electrocardiograms were observed with either treatment. The present study verifies the utility of duloxetine as an efficacious and safe treatment for both emotional and physical symptoms of MDD in this predominantly Asian patient sample.

语种: 英语
WOS记录号: WOS:000246151600013
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/65324
Appears in Collections:北京大学精神卫生研究所_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Eli Lilly, Taipei, Taiwan
2.Chang Gung Mem Hosp Linkou, Tao Yuan, Taiwan
3.Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China
4.Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China
5.Kunming Med Coll, Affiliate Hosp 1, Kunming, Peoples R China
6.Korea Univ, Coll Med, Dept Psychiat, Seoul 136701, South Korea
7.Asan Med Ctr, Dept Psychiat, Seoul, South Korea
8.Eli Lilly Canada, Lilly Res Labs, Toronto, ON, Canada
9.Eli Lilly, Intercontinental Informat Sci, Sydney, NSW, Australia

Recommended Citation:
Lee, Phil,Shu, Liang,Xu, Xiufeng,et al. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: Multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil[J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES,2007,61(3):295-307.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Lee, Phil]'s Articles
[Shu, Liang]'s Articles
[Xu, Xiufeng]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Lee, Phil]‘s Articles
[Shu, Liang]‘s Articles
[Xu, Xiufeng]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace